Press Releases

Filter Releases
 
Press Releases
Date Title and Summary View
Apr 7, 2014
nCounter PanCancer Pathways Panel Streamlines the Study of All Major Cancer Pathways and Associated Driver Genes SEATTLE & SAN DIEGO--(BUSINESS WIRE)-- NanoString Technologies, Inc., (NASDAQ:NSTG) a provider of life science tools for translational research and molecular diagn...
Apr 3, 2014
SEATTLE, April 3, 2014 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (Nasdaq:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced that it has entered into a term loan agreement with Capital Royalty L.P. and certain of its affiliates. The agreement provides NanoString with up to $4...
Mar 13, 2014
Successful Validation on the nCounter Dx Analysis System Supports ‘Decentralized' Use of the Prosigna Assay in Clinical Laboratories SEATTLE--(BUSINESS WIRE)-- NanoString Technologies, Inc., (NASDAQ:NSTG) a provider of life science tools for translational research and molecular diagnos...
Feb 26, 2014
- Strong Q4 2013 Revenue Growth of 56% Year over Year - - Record Q4 2013 Instrument Revenue of $5.3 Million, Up 109% Year over Year - - Full Year Total Revenue of $31.4 Million, Up 37% Year over Year - SEATTLE, Feb. 26, 2014 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (Nasdaq:NSTG), a provider of life science tools for tran...
Feb 19, 2014
SEATTLE, Feb. 19, 2014 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (Nasdaq:NSTG), today announced that its management is scheduled to participate in the Cowen 34th Annual Health Care Conference in Boston. NanoString management is scheduled to present on Wednesday, March 5, 2014 at 11:20 am ET. Interested parties can access the live au...
Feb 12, 2014
Authors Conclude that the PAM50-based Prosigna Assay can Predict Risk of Late Distant Recurrence Between Years Five and 15 after Diagnosis SEATTLE--(BUSINESS WIRE)-- NanoString Technologies, Inc., (NASDAQ:NSTG) a provider of life science tools for translational research and molecular diagnos...
Feb 11, 2014
nCounter® Elements™ General Purpose Reagents Expand the Company's Growing Portfolio of Solutions for Laboratories to Develop Tests for Personalized Medicine SEATTLE & SAN FRANCISCO--(BUSINESS WIRE)-- NanoString Technologies, Inc. (NASDAQ: NSTG), a provider of life science ...
Feb 5, 2014
SEATTLE, Feb. 5, 2014 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (Nasdaq:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced that the company will release 2013 fourth quarter financial results after the close of trading on Wednesday, February 26, 2014. Company management will ...
Jan 29, 2014
SEATTLE, Jan. 29, 2014 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (Nasdaq:NSTG), today announced that its management is scheduled to participate in the Leerink Swann Global Healthcare Conference 2014 in New York. NanoString management is scheduled to present on Wednesday, February 12, 2014 at 3:05 pm ET. Interested parties can access...
Jan 23, 2014
SEATTLE, Jan. 23, 2014 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc., a provider of life science tools for translational research and molecular diagnostic products, today announced the pricing of its follow-on public offering of $55 million of its common stock at a price to the public of $18.50 per share. In addition, the Company has granted th...
Jan 21, 2014
SEATTLE, Jan. 21, 2014 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc., a provider of life science tools for translational research and molecular diagnostic products, today announced the launch of a proposed follow-on public offering of $55 million of its common stock. In addition, the Company expects to grant the underwriters a 30-day option to ...
Jan 15, 2014
SEATTLE, Jan. 15, 2014 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (Nasdaq:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced that it has secured an exclusive option from Massachusetts General Hospital to license intellectual property related to a novel approach for multiplexe...
Jan 13, 2014
SEATTLE, Jan. 13, 2014 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc., a provider of life science tools for translational research and molecular diagnostic products, today announced that it has filed a registration statement with the U.S. Securities and Exchange Commission for a proposed follow-on public offering of $55 million of its common sto...
Jan 13, 2014
Approximately 55% fourth quarter and 37% full year 2013 year-over-year revenue growth anticipated Record fourth quarter instrument revenue of approximately $5.3 million, up 112% year-over-year SEATTLE, Jan. 13, 2014 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (Nasdaq:NSTG), a provider of life science tools for translational re...
Jan 6, 2014
SEATTLE, Jan. 6, 2014 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (Nasdaq:NSTG) today announced that its management is scheduled to participate in the JP Morgan 32nd Annual Healthcare Conference on January 15, 2014 in San Francisco. NanoString management is scheduled to present at 4:00pm PT/ 7:00 pm ET. Interested parties can access t...
Page: First Previous
...
...
Next Last
 
= add release to Briefcase